Substitution of lysine-181 to aspartic acid in the third transmembrane region of the endothelin (ET) type B receptor selectively reduces its high-affinity binding with ET-3 peptide.
In the G protein-coupled receptor family, a highly conserved aspartic acid located within the third transmembrane domain has been shown to be involved in ligand binding. Within the endothelin (ET) peptide receptor family, this aspartic acid has been replaced by a lysine. To assess the importance of this residue in ET binding, the lysine (position 181) of rat ET type B receptor was replaced by an aspartic acid. The effects on ligand binding and phosphoinositide turnover of both the wild-type and K181D mutant receptors were examined using transient receptor expression in COS-7 cells. Using [125I]ET-1 as the radioactive peptide ligand in displacement binding studies, the wild-type receptor displayed a typical non-isopeptide-selective binding profile with similar IC50 values (0.2-0.6 nM) for all three ET peptides (ET-1, ET-2, and ET-3). The mutant receptor showed an increase in IC50 values for ET-1 (5 nM), ET-2 (27 nM), and ET-3 (127 nM). The K181D mutant receptor still elicited full inositol phosphate (IP) accumulation responses in the presence of saturating concentrations of ETs (10 nM of ET-1, 100 nM of ET-2, or 1 microM of ET-3), indicating that the mutation did not affect G protein coupling.
D000818:Animals; D001224:Aspartic Acid / Q000737:chemistry*; D001665:Binding Sites; D002460:Cell Line; D016232:Endothelins / Q000378:metabolism*; D019204:GTP-Binding Proteins / Q000378:metabolism; D008239:Lysine / Q000737:chemistry*; D009154:Mutation; D010716:Phosphatidylinositols / Q000378:metabolism; D016133:Polymerase Chain Reaction; D011869:Radioligand Assay; D051381:Rats; D017466:Receptors, Endothelin / Q000737:chemistry* / Q000378:metabolism; D014162:Transfection
D016232:Endothelins; D010716:Phosphatidylinositols; D017466:Receptors, Endothelin; D001224:Aspartic Acid; D019204:GTP-Binding Proteins; D008239:Lysine